Primary Ciliary Dyskinesia (PCD) remains significantly underdiagnosed in patients who do not present with the classic hallmark of organ laterality defects.
This article examines the significant limitations of the PICADAR predictive tool in identifying Primary Ciliary Dyskinesia (PCD), particularly its concerning false-negative rates in patients without classic laterality defects or hallmark...
Diagnosing Primary Ciliary Dyskinesia (PCD) in patients with normal ciliary ultrastructure presents a significant challenge, requiring a shift from traditional diagnostic paradigms.
The Primary Ciliary Dyskinesia Rule (PICADAR) is a recommended predictive tool for estimating the likelihood of Primary Ciliary Dyskinesia (PCD), but recent evidence reveals critical limitations in its sensitivity, particularly...
This article provides a comprehensive analysis of the PICADAR (PrImary CiliARy DyskinesiA Rule) predictive tool for primary ciliary dyskinesia (PCD), tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of the PICADAR score's sensitivity as a predictive tool for Primary Ciliary Dyskinesia (PCD), a rare genetic disorder.
This article critically examines the diagnostic performance of the PICADAR (PrImary CiliARy DyskinesiA Rule) prediction tool in cohorts with genetically confirmed Primary Ciliary Dyskinesia (PCD).
This article provides a comprehensive analysis of the PICADAR (PrImary CiliARy DyskinesiA Rule) tool within the modern Primary Ciliary Dyskinesia (PCD) diagnostic workflow.
This article provides a critical analysis of the long-term safety profiles of major CRISPR-Cas systems, including nucleases, base editors, and prime editors, for a professional audience of researchers and drug...
This article provides a comprehensive analysis of viral and non-viral delivery vectors for CRISPR-Cas9 therapeutics, tailored for researchers and drug development professionals.